End of Enrollment for Pediatric Phase III Trial
GCT has successfully concluded enrollment for the Phase III pediatric study of rare neurological disease in Russia.
Reaching the exact recruitment number, as predicted and in under 1.5 months marks an important milestone for our company
and the Sponsor – US Pharma and GCT long term partner.
January 22, 2020
Meet our clients
All trademarks, brand names and logotypes are intellectual property of their respective owners.
Upcoming meetings
-
ISCTM 16 Annual Scientific Meeting
Grand Hyatt
Washington, District of Columbia, USA
2020, February 18—19 -
European Site Solutions Summit
Hotel Cascais Miragem
Lisbon, Portugal
2020, March 9—10 -
MAGI 2020 East
Loews Philadelphia
Philadelphia, PA, USA
2020, April 19—22 -
Clinical Trials Innovation Programme
Munich Airport Marriott Hotel
Munich, Germany
2020, April 23—24
